MARKET

WGS

WGS

GeneDx Holdings Corp
NASDAQ
69.82
+1.15
+1.67%
After Hours: 68.70 -1.12 -1.60% 19:58 06/26 EDT
OPEN
67.68
PREV CLOSE
68.67
HIGH
71.35
LOW
67.40
VOLUME
1.38M
TURNOVER
--
52 WEEK HIGH
170.87
52 WEEK LOW
32.21
MARKET CAP
2.07B
P/E (TTM)
-26.1665
1D
5D
1M
3M
1Y
5Y
1D
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
PR Newswire · 19h ago
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
PR Newswire · 1d ago
GeneDx Holdings (WGS) Names Mark Gardner President, Is It Still Below Fair Value?
Simply Wall St · 2d ago
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit
PR Newswire · 2d ago
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - HBSS
PR Newswire · 3d ago
Robbins LLP Urges WGS Stockholders Who Lost Money Investing in GeneDx Holdings Corp. to Contact the Firm for Information About Leading the Class Action
PR Newswire · 3d ago
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 4d ago
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%
The Motley Fool · 4d ago
More
About WGS
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

Webull offers GeneDx Holdings Corp stock information, including NASDAQ: WGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WGS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WGS stock methods without spending real money on the virtual paper trading platform.